Avian flu has reached new corners of the globe and become endemic for the first time in some wild birds that transmit the virus to poultry, according to veterinarians and disease experts, who warn it is now a year-round problem.
Featured Posts
The U.S. health department proposed on Tuesday three new pilot projects aimed at lowering prescription drug prices for people enrolled in government health insurance plans, including offering some essential generic drugs for $2 a month.
Danish pharmaceuticals company Bavarian Nordic has agreed to buy a portfolio of travel vaccines from Emergent BioSolutions Inc. for up to $380 million, it said on Wednesday after delivering an upbeat outlook for 2023.
After nearly three years, the COVID-19 research collaboration between Vir Biotechnology and GSK has largely come to an end, as Vir announced Monday it would be going it alone or with other partners in this space.
The bankruptcy case filed by Johnson & Johnson’s subsidiary shouldering talc-related lawsuits will soon be dismissed unless a U.S appeals court agrees to reconsider its decision to nix the company’s attempt to offload the litigation into Chapter 11 proceedings, a federal judge said on Tuesday.
The World Health Organization is increasing its epidemiological surveillance in Equatorial Guinea after the country confirmed its first outbreak of the Marburg virus, a WHO official said on Tuesday.
Vivek Ramaswamy, the founder of Roivant Sciences, is considering a bid for the Republican presidential nomination, according to a report by POLITICO Monday.
Fresh off of his Sanofi exit, John Reed is joining Johnson & Johnson, where he will serve as executive vice president, pharmaceuticals, R&D, the New Jersey-based company announced late Monday afternoon.
As oncology drugs receive accelerated approvals, payers are questioning whether the benefits of these products outweigh the cost, spurring manufacturers to explore value-based agreements.
As COVID ripped across China and filled emergency wards, privileged patients cut hospital queues because they knew someone, offered a bribe or paid people with connections, said three people who accessed care through such means and seven doctors in six cities.